Search Results - "Ungerstedt, Johanna"

Refine Results
  1. 1

    Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors by Ungerstedt, Johanna S

    “…Myeloid hematological malignancies are clonal bone marrow neoplasms, comprising of acute myeloid leukemia (AML), the myelodysplastic syndromes (MDS), chronic…”
    Get full text
    Journal Article
  2. 2

    KIT signaling is dispensable for human mast cell progenitor development by Dahlin, Joakim S., Ekoff, Maria, Grootens, Jennine, Löf, Liza, Amini, Rose-Marie, Hagberg, Hans, Ungerstedt, Johanna S., Olsson-Strömberg, Ulla, Nilsson, Gunnar

    Published in Blood (19-10-2017)
    “…Human hematopoietic progenitors are generally assumed to require stem cell factor (SCF) and KIT signaling during differentiation for the formation of mast…”
    Get full text
    Journal Article
  3. 3
  4. 4

    The functional and molecular impact of triamcinolone acetonide on primary human bone marrow mesenchymal stem cells by Kumlin, Maritha, Ungerstedt, Johanna, Cai, Huan, Leonard, Elory, Felländer-Tsai, Li, Qian, Hong

    Published in Scientific reports (08-12-2023)
    “…Traumatic or degenerative joint pain is abundant in the population. Symptom relief by intra- and periarticular glucocorticoid administration is frequently…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells by Grootens, Jennine, Ungerstedt, Johanna S., Nilsson, Gunnar, Dahlin, Joakim S.

    Published in Blood advances (11-09-2018)
    “…Hematopoietic stem cells differentiate into all types of blood cells, including peripheral tissue-resident mast cells. The early mast cell differentiation…”
    Get full text
    Journal Article
  9. 9

    Motexafin Gadolinium, a Tumor-selective Drug Targeting Thioredoxin Reductase and Ribonucleotide Reductase by Hashemy, Seyed Isaac, Ungerstedt, Johanna S., Avval, Farnaz Zahedi, Holmgren, Arne

    Published in The Journal of biological chemistry (21-04-2006)
    “…Motexafin gadolinium (MGd) is a chemotherapeutic drug that selectively targets tumor cells and mediates redox reactions generating reactive oxygen species…”
    Get full text
    Journal Article
  10. 10

    Localization-Specific Expression of CCR1 and CCR5 by Mast Cell Progenitors by Salomonsson, Maya, Dahlin, Joakim S, Ungerstedt, Johanna, Hallgren, Jenny

    Published in Frontiers in immunology (2020)
    “…Mast cells are powerful immune cells found predominately in barrier tissues. They play an important role in immune surveillance and act as effector cells in…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Single-cell transcriptomics reveals the identity and regulators of human mast cell progenitors by Wu, Chenyan, Boey, Daryl, Bril, Oscar, Grootens, Jennine, Vijayabaskar, M.S., Sorini, Chiara, Ekoff, Maria, Wilson, Nicola K., Ungerstedt, Johanna S., Nilsson, Gunnar, Dahlin, Joakim S.

    Published in Blood advances (09-08-2022)
    “…Mast cell accumulation is a hallmark of a number of diseases, including allergic asthma and systemic mastocytosis. Immunoglobulin E–mediated crosslinking of…”
    Get full text
    Journal Article
  14. 14

    Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis by Grootens, Jennine, Ungerstedt, Johanna S., Ekoff, Maria, Rönnberg, Elin, Klimkowska, Monika, Amini, Rose-Marie, Arock, Michel, Söderlund, Stina, Mattsson, Mattias, Nilsson, Gunnar, Dahlin, Joakim S.

    Published in EBioMedicine (01-05-2019)
    “…Systemic mastocytosis (SM) is a haematological disease characterised by organ infiltration by neoplastic mast cells. Almost all SM patients have a mutation in…”
    Get full text
    Journal Article
  15. 15

    Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels by Nair, Deepika, Rådestad, Emelie, Khalkar, Prajakta, Diaz-Argelich, Nuria, Schröder, Axel, Klynning, Charlotte, Ungerstedt, Johanna, Uhlin, Michael, Fernandes, Aristi P

    Published in Frontiers in oncology (2018)
    “…Redox active selenium (Se) compounds at sub toxic doses act as pro-oxidants with cytotoxic effects on tumor cells and are promising future chemotherapeutic…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetes by Du, Yatao, Zhang, Huihui, Montano, Sergio, Hegestam, Jesper, Ekberg, Neda Rajamand, Holmgren, Arne, Brismar, Kerstin, Ungerstedt, Johanna S.

    Published in Acta diabetologica (01-04-2014)
    “…Oxidative stress induced by hyperglycemia is a key factor in the pathogenesis of diabetes complications. Glutaredoxin 1(Grx1) is a cytosolic redox protein that…”
    Get full text
    Journal Article
  19. 19

    Glutaredoxin mediated redox effects of coenzyme Q10 treatment in type 1 and type 2 diabetes patients by Montano, Sergio J., Grünler, Jacob, Nair, Deepika, Tekle, Michael, Fernandes, Aristi P., Hua, Xiang, Holmgren, Arne, Brismar, Kerstin, Ungerstedt, Johanna S.

    Published in BBA clinical (01-12-2015)
    “…The possible beneficial effects of coenzyme Q10 (CoQ10) supplementation on disease progression and oxidant status in diabetes remains debated. In the present…”
    Get full text
    Journal Article
  20. 20